Credence Research Logo

Home » Healthcare » South Korea Single-Use Bio-Processing Systems Market

South Korea Single-Use Bio-Processing Systems Market By Type (Single-Use Bioreactors, Single-Use Mixers, Single-Use Bags, Single-Use Connectors, Others); By Application (Research & Development, Manufacturing, Process Development, Commercial Production, Others); By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations [CROs], Academic & Research Institutes, Contract Manufacturing Organizations [CMOs], Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Report ID: 93669 | Report Format : Excel, PDF

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
South Korea Single-Use Bio-Processing Systems Market Size 2024 USD 737.89 million
South Korea Single-Use Bio-Processing Systems Market, CAGR 16.84%
South Korea Single-Use Bio-Processing Systems Market Size 2032 USD 2,562.50 million

Market Overview

South Korea Single-Use Bio-Processing Systems market size was valued at USD 737.89 million in 2024 and is anticipated to reach USD 2,562.50 million by 2032, at a CAGR of 16.84% during the forecast period (2024-2032).

The South Korean Single-Use Bio-Processing Systems market is driven by the increasing demand for cost-effective and flexible manufacturing solutions in the biopharmaceutical industry. These systems offer advantages such as reduced risk of cross-contamination, faster production timelines, and lower operational costs, making them an attractive choice for companies. The growing trend towards personalized medicine and biologics production further fuels the adoption of single-use technologies. Additionally, government initiatives supporting the biopharmaceutical sector and advancements in disposable technology are expected to accelerate market growth. As the demand for biologics continues to rise, single-use systems are becoming integral to ensuring scalability, efficiency, and compliance with stringent regulatory standards. Furthermore, the shift toward sustainability, with an emphasis on reducing environmental impact, is pushing companies to adopt more eco-friendly, disposable alternatives to traditional multi-use equipment, further contributing to the market’s expansion in South Korea.

The South Korea single-use bio-processing systems market is geographically concentrated in key regions, including the Seoul Metropolitan area, Gyeonggi Province, and Busan, with these regions housing the majority of biopharmaceutical manufacturers and research facilities. Seoul and its surrounding areas benefit from robust infrastructure, government support, and a strong concentration of life sciences companies, making them the primary hubs for biopharmaceutical production and R&D. Gyeonggi Province is also a significant player due to its industrial capacity and proximity to Seoul, supporting increased adoption of single-use systems in manufacturing and process development. Key players in the South Korean market include global companies such as Wuxi AppTec, FUJIFILM Irvine Scientific, Cytiva, and Thermo Fisher Scientific Asia, which provide cutting-edge technologies for bioprocessing. Local players like Shanghai Bailun Biotechnology Co., Ltd. and Merck Life Science are also contributing to the region’s growth through innovative product offerings and strategic investments.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Insights

  • The South Korea single-use bio-processing systems market was valued at USD 737.89 million in 2024 and is projected to reach USD 2,562.50 million by 2032, growing at a CAGR of 16.84% during the forecast period.
  • The global single-use bio-processing systems market was valued at USD 17,326.05 million in 2024 and is projected to reach USD 57,663.39 million by 2032, growing at a CAGR of 16.22% from 2024 to 2032.
  • Increasing demand for biologics and personalized medicine is driving market growth, as single-use systems offer flexibility, cost-efficiency, and scalability in production.
  • Advancements in disposable bioprocessing technologies, such as sensors and automation, are boosting system efficiency and expanding their applications.
  • Key players like Wuxi AppTec, Cytiva, and FUJIFILM Irvine Scientific dominate the market, intensifying competition with innovative product offerings and strategic partnerships.
  • High initial investment costs for implementing single-use systems remain a challenge for some manufacturers, especially smaller companies.
  • Environmental concerns regarding the disposal of single-use components are raising sustainability challenges in the market.
  • The Seoul Metropolitan and Gyeonggi regions are major hubs for bio-processing activity, attracting both local and international investments.

Report Scope

This report segments the South Korea Single-Use Bio-Processing Systems Market as follows:

South Korea Single-Use Bio-Processing Systems Market
South Korea Single-Use Bio-Processing Systems Market

Market Drivers

Rising Demand for Biopharmaceuticals

The increasing global demand for biopharmaceuticals is a significant driver for the growth of the South Korea Single-Use Bio-Processing Systems market. As the production of biologics, such as monoclonal antibodies, vaccines, and gene therapies, continues to expand, there is a heightened need for flexible and efficient manufacturing solutions. For instance, the Korea Biotechnology Industry Organization (KoreaBIO) has reported a surge in biologics production, driven by the growing prevalence of chronic diseases and the need for scalable manufacturing technologies. Single-use technologies address these needs by offering a streamlined production process, reducing contamination risks, and lowering operational costs compared to traditional stainless-steel systems. The surge in biologics production, driven by the growing prevalence of chronic diseases, cancer, and other health conditions, has placed a premium on fast, scalable, and cost-effective bioprocessing technologies. This trend positions single-use systems as a preferred choice for biopharmaceutical companies in South Korea, fostering market growth.

Government Support and Regulatory Compliance

The South Korean government plays a key role in promoting the growth of the biopharmaceutical industry, which in turn drives the demand for single-use bio-processing systems. Through initiatives such as funding for research and development, infrastructure development, and regulatory frameworks aimed at supporting the growth of the life sciences sector, the government is encouraging the adoption of advanced manufacturing technologies. For instance, the Ministry of Food and Drug Safety (MFDS) has introduced regulatory guidelines to streamline the approval process for single-use bioprocessing technologies, ensuring compliance with international standards. Additionally, stringent regulatory requirements for biopharmaceutical production are driving the need for more efficient, compliant, and scalable processing systems. Single-use technologies offer the flexibility to meet these regulations, particularly in terms of minimizing the risk of contamination and improving traceability, which is essential for ensuring product safety and compliance with South Korea’s pharmaceutical regulatory standards. This support further accelerates the adoption of single-use systems in the local market.

Cost Efficiency and Flexibility

Cost efficiency and flexibility are central advantages of single-use bio-processing systems, contributing significantly to their increasing adoption in South Korea. Traditional multi-use equipment involves high upfront capital costs, extensive cleaning procedures, and maintenance, which can be resource-intensive and time-consuming. In contrast, single-use systems reduce the need for cleaning and sterilization, minimizing downtime and labor costs. This allows for faster turnarounds in production and enhanced scalability, which is critical for manufacturers handling smaller batch sizes or working with multiple products. These systems also offer greater flexibility, allowing companies to easily switch between products without the risk of cross-contamination, making them an attractive choice for companies in South Korea focused on optimizing operational efficiency.

Advancements in Disposable Technologies

Ongoing advancements in disposable technologies are enhancing the performance and capabilities of single-use bio-processing systems, further driving market growth in South Korea. Innovations in materials, system design, and automation are making these systems increasingly efficient and cost-effective. For example, new bioreactor designs, more durable and reliable components, and improved data integration capabilities are expanding the range of applications for single-use technologies. Moreover, advancements in sensor technology, monitoring systems, and process control systems have significantly improved the accuracy and reliability of these systems, ensuring higher productivity and consistent product quality. These advancements are expected to foster broader adoption of single-use bio-processing systems in South Korea’s growing biopharmaceutical market.

Market Trends

Surge in Biopharmaceutical Production and Demand for Personalized Medicine

The South Korean market for Single-Use Bio-Processing Systems is experiencing rapid growth, largely due to the increasing demand for biopharmaceuticals and the shift towards personalized medicine. The biopharmaceutical sector is expanding with the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, as well as the growing need for vaccines and biologics. Personalized medicine, which tailors treatments based on individual genetic profiles, is gaining traction in South Korea, further driving the demand for flexible, scalable, and cost-effective manufacturing solutions. For instance, Samsung Biologics has expanded its single-use bioprocessing capabilities to meet the rising demand for biologics and biosimilars in South Korea. Single-use systems provide an optimal solution for these needs, enabling quicker turnarounds, reducing cross-contamination risks, and lowering operational costs. As these systems support both large-scale biologics production and smaller, patient-specific batches, they are positioned as a crucial component of South Korea’s biopharmaceutical manufacturing landscape.

Shift Toward Smart Manufacturing and Automation

A notable trend in the South Korean single-use bio-processing market is the increasing adoption of smart manufacturing solutions. The integration of automation, data analytics, and real-time process monitoring is transforming the way biomanufacturing processes are managed. Smart manufacturing technologies allow for higher precision, efficiency, and scalability in production. For instance, the Korea Institute for Industrial Economics & Trade (KIET) has published reports on smart factory policies, highlighting the role of automation in improving productivity in biomanufacturing. These systems enable manufacturers to monitor and control every aspect of the bioprocessing operation, from raw material input to final product output, in real-time. By minimizing human intervention and reducing the risk of errors, smart manufacturing solutions enhance product quality and consistency. Additionally, the use of artificial intelligence and machine learning for predictive analytics further optimizes production processes, helping companies identify inefficiencies, reduce downtime, and improve overall yield. This move toward smart manufacturing is not only improving operational efficiency but also enabling South Korea’s biomanufacturers to maintain a competitive edge in the global market.

Technological Advancements in Disposable Bioprocessing Equipment

Technological advancements are significantly shaping the growth of the single-use bio-processing market in South Korea. Innovations in disposable bioprocessing equipment are enhancing system performance, reliability, and cost-efficiency. For instance, the development of advanced materials, such as improved plastics and hybrid materials, has led to more durable and efficient bioreactors, filtration devices, and other components. Additionally, the integration of advanced sensor technology, real-time monitoring systems, and process automation has improved the overall performance of these systems. These innovations allow for better process control, higher yields, and more precise data collection, which is essential for maintaining product quality and regulatory compliance. As these technologies continue to evolve, they are making single-use bio-processing systems even more efficient and adaptable to a wide range of biopharmaceutical manufacturing processes.

Government Initiatives and Industry Support

The South Korean government plays a pivotal role in fostering the growth of the biopharmaceutical industry, which, in turn, is driving the adoption of single-use bio-processing systems. The government has implemented various initiatives to support the development of the biotechnology sector, including funding for research and development, infrastructure improvements, and regulatory frameworks designed to enhance the growth of the life sciences industry. The establishment of policies such as the “Advanced Bio Initiative,” aimed at promoting digital bio and the convergence of innovation-based technologies, highlights the government’s commitment to advancing biomanufacturing capabilities. These policies not only encourage the growth of biopharmaceutical production but also facilitate the adoption of cutting-edge technologies like single-use bio-processing systems. Additionally, South Korea’s focus on creating a favorable regulatory environment for biotech companies ensures that these companies can easily comply with the strict regulatory standards governing biopharmaceutical production, further boosting the demand for disposable bioprocessing solutions.

Market Challenges Analysis

High Initial Investment Costs

One of the significant challenges in the adoption of single-use bio-processing systems in South Korea is the high initial investment required for these technologies. Although single-use systems offer long-term operational cost savings by reducing the need for cleaning, maintenance, and sterilization, the upfront costs can be considerable. The price of purchasing and setting up disposable bioprocessing equipment, along with the necessary infrastructure for integration into existing manufacturing systems, poses a barrier, particularly for smaller or mid-sized companies. Additionally, the cost of training personnel and maintaining a steady supply of disposable components can add to the financial burden. These high initial costs may deter some companies from adopting single-use technologies, especially when they are operating on tight budgets or uncertain demand forecasts. The financial challenge of upgrading to or integrating these systems requires careful consideration of long-term benefits versus immediate expenditures.

Limited Recycling and Sustainability Issues

Another challenge facing the South Korean single-use bio-processing market is the environmental impact associated with the disposal of single-use components. Although these systems reduce contamination risks and improve operational efficiency, they generate substantial waste, including plastics, filters, and bags. For instance, the Ministry of Environment of South Korea has introduced stricter regulations on plastic waste management, encouraging biopharmaceutical companies to adopt sustainable practices. The inability to recycle these components in many cases raises concerns about the sustainability of single-use technologies. As governments and industries worldwide focus on environmental sustainability, bio-processing companies may face increasing pressure to reduce their environmental footprint. In South Korea, this concern is becoming more pronounced as the country aims to meet international sustainability goals. Companies in the biopharmaceutical sector must find innovative solutions for waste management or explore recycling options to address these environmental challenges. Balancing the convenience and efficiency of single-use systems with the growing need for sustainability could pose a challenge in the years ahead, requiring both technological and operational advancements.

Market Opportunities

The South Korean single-use bio-processing systems market presents several significant opportunities driven by the country’s growing biopharmaceutical sector and advancements in technology. As the demand for biologics and personalized medicine increases, there is an opportunity for bio-processing companies to expand their use of single-use systems. These systems offer flexibility, scalability, and cost-efficiency, making them ideal for the production of small and medium-sized batches typical of personalized therapies. With the increasing prevalence of chronic diseases, cancer, and genetic disorders, South Korea’s biopharmaceutical industry is poised for substantial growth, driving the need for more efficient production methods. Manufacturers can leverage single-use systems to accelerate time-to-market for novel treatments, positioning themselves to meet the increasing demand for personalized and biologic drugs. This creates a robust market opportunity for suppliers of single-use bio-processing technologies.

Moreover, South Korea’s strong focus on technological innovation and sustainability presents additional growth prospects for the single-use bio-processing systems market. As the industry continues to prioritize automation, data integration, and smart manufacturing solutions, the demand for advanced, automated single-use technologies is likely to increase. Innovations in disposable components, such as sensors, monitoring systems, and bioreactors, are enabling more efficient and precise manufacturing processes. Additionally, with increasing global emphasis on sustainability, there is growing interest in developing environmentally friendly, recyclable single-use components. This trend could offer companies the opportunity to differentiate themselves by providing eco-friendly solutions, tapping into the broader movement toward sustainable manufacturing practices. By capitalizing on these technological advancements and sustainability trends, companies in the South Korean market can strengthen their position in the rapidly evolving global biopharmaceutical landscape.

Market Segmentation Analysis:

By Type:

The South Korean single-use bio-processing systems market is segmented by type, with each component offering distinct advantages in biopharmaceutical production. Single-use bioreactors are one of the largest segments, driven by their ability to handle small- to medium-scale production efficiently and cost-effectively. These bioreactors reduce contamination risks and eliminate the need for time-consuming cleaning and sterilization processes. Single-use mixers are another important component, widely used for fluid mixing in various biopharmaceutical applications. They offer enhanced flexibility and a more streamlined process compared to traditional multi-use systems. Single-use bags are also crucial in bio-processing, providing an easy solution for storing and transporting media and biologics. Similarly, single-use connectors are essential for ensuring secure and sterile connections between components in bioreactor and filtration systems. The “Others” segment includes a variety of additional disposable components such as filters, sensors, and pumps. Each of these products contributes to the growing adoption of single-use technologies in South Korea’s biopharmaceutical industry.

By Application:

The market for single-use bio-processing systems in South Korea can also be segmented by application. Research & development (R&D) is a key segment, as single-use systems are ideal for developing and testing new biologic drugs and therapies. These systems offer the flexibility needed for experimentation while reducing costs and contamination risks. In the manufacturing segment, single-use systems are increasingly being adopted due to their scalability and operational efficiency, particularly in the production of small batches or personalized medicines. The process development segment benefits from single-use systems’ ability to streamline the transition from laboratory-scale to production-scale operations. Commercial production also represents a significant application area, as companies in South Korea seek faster time-to-market and improved cost-efficiency in large-scale biologic manufacturing. Finally, the “Others” segment includes additional applications such as contract manufacturing and the production of biosimilars, further expanding the scope of single-use technologies in South Korea’s dynamic bio-processing market.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Segments:

Based on Type:

  • Single-Use Bioreactors
  • Single-Use Mixers
  • Single-Use Bags
  • Single-Use Connectors
  • Others

Based on Application:

  • Research & Development
  • Manufacturing
  • Process Development
  • Commercial Production
  • Others

Based on End- User:

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutes
  • Contract Manufacturing Organizations (CMOs)
  • Others

Based on the Geography:

  • Seoul Metropolitan Region
  • Gyeonggi Province
  • Busan and Ulsan Regions
  • Daegu Region

Regional Analysis

Seoul Metropolitan Region

The Seoul Metropolitan Region holds the largest market share, accounting for approximately 45% of the total market. This region is the heart of South Korea’s biopharmaceutical industry, housing major pharmaceutical companies, research institutions, and regulatory bodies. The strong presence of R&D facilities, coupled with a high concentration of biotechnology and life sciences companies, drives demand for advanced bio-processing technologies. Additionally, the proximity to global markets, access to skilled talent, and government initiatives supporting innovation further solidify Seoul’s dominant position in the single-use bio-processing systems market.

Gyeonggi Province

Gyeonggi Province follows closely, with a market share of about 30%. This region is strategically important due to its proximity to Seoul and its well-developed industrial infrastructure. Gyeonggi Province is home to several industrial clusters that support biopharmaceutical manufacturing and R&D activities. The region is seeing increased investments in biotechnology and biomanufacturing, which has led to a growing adoption of single-use systems in various stages of drug development and commercial production. Gyeonggi’s focus on expanding its life sciences sector and attracting foreign investment in biomanufacturing further enhances its market share in this segment.

Busan and Ulsan Regions

The Busan and Ulsan Regions account for around 10% of the market share. These regions have been investing heavily in diversifying their economies, with a strong focus on biotechnology, healthcare, and manufacturing. Busan, as a major port city, is central to South Korea’s international trade and logistics, making it an ideal location for pharmaceutical manufacturers seeking to export products. Ulsan, known for its heavy industries, is diversifying into high-tech industries, including biopharmaceuticals. While these regions are still developing their biomanufacturing capabilities compared to Seoul and Gyeonggi, their growing infrastructure and industry support are boosting the adoption of single-use bio-processing systems.

Daegu Region

The Daegu Region holds a market share of approximately 5%. Known for its strong presence in textiles and electronics, Daegu has been working to diversify its economy, with an increasing emphasis on biopharmaceuticals. While the region currently holds a smaller share of the market, its focus on research and innovation in life sciences, particularly in regenerative medicine and biologics, is expected to drive future demand for single-use bio-processing systems. Government initiatives and academic institutions in Daegu are gradually enhancing the region’s biomanufacturing capabilities, positioning it for future growth in the bio-processing sector.

Key Player Analysis

  • Wuxi AppTec
  • Shanghai Bailun Biotechnology Co., Ltd.
  • Tsinghua University Suzhou Institute for Biomedicine
  • FUJIFILM Irvine Scientific
  • Cytiva
  • Hitachi Chemical Co., Ltd.
  • Mitsubishi Gas Chemical Company, Inc.
  • Merck Life Science
  • Thermo Fisher Scientific Asia
  • Danaher Asia-Pacific

Competitive Analysis

The South Korea single-use bio-processing systems market is highly competitive, with several global and regional players vying for market share through product innovation, strategic partnerships, and geographic expansion. Leading players such as Wuxi AppTec, FUJIFILM Irvine Scientific, Cytiva, Thermo Fisher Scientific Asia, Shanghai Bailun Biotechnology Co., Ltd., Merck Life Science, Hitachi Chemical Co., Ltd., Mitsubishi Gas Chemical Company, Inc., and Danaher Asia-Pacific are driving the market forward. These companies offer a wide range of single-use systems, including bioreactors, mixers, bags, connectors, and filtration products, all designed to streamline biomanufacturing processes while improving efficiency and reducing contamination risks. Companies are focusing on product diversification and the development of advanced solutions such as automated systems, sensors, and real-time data integration, which enhance operational efficiency and scalability in biomanufacturing. Additionally, the increasing demand for biologics, biosimilars, and personalized medicine has spurred competition, as manufacturers seek flexible, cost-effective, and scalable production systems that reduce contamination risks and improve turnaround times. To maintain a competitive edge, market players are investing in R&D to improve the performance and reliability of their products, while also exploring opportunities in emerging markets. The competition is further intensified by the growing importance of environmental sustainability, with many companies adopting eco-friendly technologies and reducing waste associated with single-use systems. Partnerships, collaborations, and acquisitions are common strategies in this competitive landscape, enabling companies to expand their product offerings and enhance their market presence. As the market for single-use bio-processing systems in South Korea continues to grow, competition will likely continue to drive innovation and shape the future of biopharmaceutical manufacturing.

Recent Developments

  • In April 2025, Thermo Fisher Scientific launched the 5L DynaDrive Single-Use Bioreactor, a bench-scale system designed for seamless scalability from 1 to 5,000 liters. This new bioreactor offers a 27% productivity increase over glass bioreactors, enhanced sustainability with biobased films, and consistent performance across different scales, supporting both large and small biopharma manufacturers. The DynaDrive S.U.B. supports robust production across scales and has the flexibility to accommodate a variety of cell lines and processing modalities.
  • In April 2025, Sartorius Stedim Biotech entered a strategic partnership with Tulip Interfaces to drive digital transformation in single-use bioprocessing. The collaboration introduced Biobrain® Operate powered by Tulip, a suite of digital manufacturing applications that integrate with Sartorius equipment to reduce process variability, digitize operations, and ensure regulatory compliance. This partnership aims to advance paperless manufacturing and optimize resource efficiency in bioprocessing.
  • In March 2025, Corning introduced new technologies to support advanced therapy applications, including the Ascent™ Fixed Bed Reactor (FBR) and expanded cell expansion platforms like HYPERStack®, HYPERFlask®, and CellSTACK®. These platforms feature closed systems and automation to reduce contamination risk and enhance scalability for bioprocess applications.
  • In April 2023, Merck KGaA launched the Ultimus® Single-Use Process Container Film, featuring ten times greater abrasion resistance than other films, improved durability, and leak resistance for single-use assemblies. The technology is now available in Mobius® 3D process containers, enhancing operational efficiency and cell growth performance.

Market Concentration & Characteristics

The South Korea single-use bio-processing systems market exhibits moderate concentration, with a few key players holding significant market shares while also accommodating a number of regional and emerging companies. The market is characterized by high levels of innovation, driven by global industry leaders that provide a diverse range of products, including bioreactors, mixers, bags, and connectors, designed to streamline biomanufacturing processes. As the demand for biologics, personalized medicine, and scalable production systems increases, established players are expanding their portfolios and forming strategic partnerships to enhance product offerings. Market characteristics include a strong emphasis on technological advancements such as automation, real-time monitoring, and data integration, which are critical for improving efficiency and reducing contamination risks. Additionally, there is growing pressure to address sustainability concerns, leading companies to innovate in waste reduction and the development of environmentally friendly solutions. The combination of technological focus, strategic alliances, and sustainability initiatives shapes the competitive dynamics of this market.

Report Coverage

The research report offers an in-depth analysis based on Type, Application, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The South Korean single-use bio-processing systems market is projected to continue its robust growth trajectory, driven by the increasing demand for biologics and personalized medicines.
  2. Advancements in automation and data analytics are expected to enhance process efficiency, reduce contamination risks, and improve product quality in biomanufacturing.
  3. The integration of artificial intelligence and machine learning into bioprocessing workflows will facilitate real-time monitoring, predictive analytics, and process optimization.
  4. Government initiatives, such as the establishment of the National Bio Committee, aim to streamline bio-related policies and foster innovation in the biotechnology sector.
  5. The development of local manufacturing capabilities for single-use components will mitigate supply chain vulnerabilities and reduce dependence on global suppliers.
  6. Collaborations between industry stakeholders and regulatory bodies are anticipated to lead to the establishment of standardized guidelines, promoting the widespread adoption of single-use technologies.
  7. Investment in education and training programs will address the skilled workforce gap, ensuring proficiency in advanced bioprocessing technologies.
  8. The focus on sustainability will drive the development of eco-friendly single-use components, aligning with global environmental standards.
  9. The expansion of biopharmaceutical manufacturing facilities in regions like Osong Life Science Complex will bolster production capacity and support industry growth.
  10. The increasing adoption of single-use systems in contract manufacturing organizations (CMOs) will enhance flexibility and scalability in biopharmaceutical production.

CHAPTER NO. 1 : INTRODUCTION 19

1.1.1. Report Description 19

Purpose of the Report 19

USP & Key Offerings 19

1.1.2. Key Benefits for Stakeholders 19

1.1.3. Target Audience 20

1.1.4. Report Scope 20

CHAPTER NO. 2 : EXECUTIVE SUMMARY 21

2.1. Single-Use Bio-Processing Systems Market Snapshot 21

2.1.1. South Korea Single-Use Bio-Processing Systems Market, 2018 – 2032 (USD Million) 22

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 23

3.1. Russia-Ukraine and Israel-Palestine War Impacts 23

CHAPTER NO. 4 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – INDUSTRY ANALYSIS 24

4.1. Introduction 24

4.2. Market Drivers 25

4.2.1. Growing Adoption of Disposable Technologies in Biopharmaceutical Manufacturing 25

4.2.2. Increasing Demand for Cost-Effective and Scalable Bioprocessing Solutions 26

4.3. Market Restraints 27

4.3.1. Concerns Related to Leachables and Extractables in Single-Use Systems 27

4.4. Market Opportunities 28

4.4.1. Advancements in Bioprocessing Technology Driving Innovation in Single-Use Systems 28

4.5. Porter’s Five Forces Analysis 29

4.6. Buying Criteria 30

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 31

5.1. Import Analysis by South Korea 31

5.1.1. South Korea Single-Use Bio-Processing Systems Market Import Volume/Revenue, By South Korea, 2018 – 2023 31

5.2. Export Analysis by South Korea 32

5.2.1. South Korea Single-Use Bio-Processing Systems Market Export Volume/Revenue, By South Korea, 2018 – 2023 32

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 33

6.1. Demand Analysis by South Korea 33

6.1.1. South Korea Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By South Korea, 2018 – 2023 33

6.2. Supply Analysis by South Korea 34

6.2.1. South Korea Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By South Korea, 2018 – 2023 34

CHAPTER NO. 7 : PRODUCTION ANALYSIS 35

7.1. Production Analysis by South Korea 35

7.1.1. South Korea Single-Use Bio-Processing Systems Market Production Volume/Revenue, By South Korea, 2018 – 2023 35

CHAPTER NO. 8 : PRICE ANALYSIS 36

8.1. Price Analysis by Type 36

8.1.1. South Korea Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

8.1.2. South Korea Type Market Price, By Type, 2018 – 2023 36

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 37

9.1. Key Raw Materials and Suppliers 37

9.2. Key Raw Materials Price Trend 37

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 38

10.1. Manufacturing Cost Analysis 38

10.2. Manufacturing Process 38

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 39

11.1. Company Market Share Analysis – 2023 39

11.2. Value Chain Analysis 39

11.2.1. South Korea Single-Use Bio-Processing Systems Market: Company Market Share, by Volume, 2023 40

11.2.2. South Korea Single-Use Bio-Processing Systems Market: Company Market Share, by Revenue, 2023 41

11.2.3. South Korea Single-Use Bio-Processing Systems Market: Top 6 Company Market Share, by Revenue, 2023 41

11.2.4. South Korea Single-Use Bio-Processing Systems Market: Top 3 Company Market Share, by Revenue, 2023 42

11.3. South Korea Single-Use Bio-Processing Systems Market Company Volume Market Share, 2023 43

11.4. South Korea Single-Use Bio-Processing Systems Market Company Revenue Market Share, 2023 44

11.5. Company Assessment Metrics, 2023 44

11.5.1. Stars 44

11.5.2. Emerging Leaders 44

11.5.3. Pervasive Players 44

11.5.4. Participants 44

11.6. Start-ups /SMEs Assessment Metrics, 2023 44

11.6.1. Progressive Companies 44

11.6.2. Responsive Companies 45

11.6.3. Dynamic Companies 45

11.6.4. Starting Blocks 45

11.7. Strategic Developments 46

11.7.1. Acquisitions & Mergers 46

New Product Launch 46

South Korea Expansion 46

11.8. Key Players Product Matrix 47

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 48

12.1. PESTEL 48

12.1.1. Political Factors 48

12.1.2. Economic Factors 48

12.1.3. Social Factors 48

12.1.4. Technological Factors 48

12.1.5. Environmental Factors 48

12.1.6. Legal Factors 48

12.2. Adjacent Market Analysis 48

CHAPTER NO. 13 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY TYPE SEGMENT ANALYSIS 49

13.1. Single-Use Bio-Processing Systems Market Overview, by Type Segment 49

13.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

13.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Type 51

13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 51

13.1.4. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

13.2. Single-Use Bioreactors 53

13.3. Single-Use Mixers 54

13.4. Single-Use Bags 55

13.5. Single-Use Connectors 56

13.6. Others 57

CHAPTER NO. 14 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY APPLICATION SEGMENT ANALYSIS 58

14.1. Single-Use Bio-Processing Systems Market Overview, by Application Segment 58

14.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

14.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By Application 60

14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 60

14.1.4. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

14.2. Research & Development 62

14.3. Manufacturing 63

14.4. Process Development 64

14.5. Commercial Production 65

14.6. Others 66

CHAPTER NO. 15 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – BY END-USER SEGMENT ANALYSIS 67

15.1. Single-Use Bio-Processing Systems Market Overview, by End-user Segment 67

15.1.1. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

15.1.2. Single-Use Bio-Processing Systems Market Attractiveness Analysis, By End-user 69

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 69

15.1.4. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

15.2. Pharmaceutical & Biotechnology Companies 71

15.3. Contract Research Organizations (CROs) 72

15.4. Academic & Research Institutes 73

15.5. Contract Manufacturing Organizations (CMOs) 74

15.6. Others 75

CHAPTER NO. 16 : SINGLE-USE BIO-PROCESSING SYSTEMS MARKET – SOUTH KOREA ANALYSIS 76

16.1. Type 76

16.1.1. South Korea Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

16.2. South Korea Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

16.3. Application 77

16.3.1. South Korea Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

16.3.2. South Korea Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

16.4. End-user 78

16.4.1. South Korea Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

16.4.2. South Korea Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

CHAPTER NO. 17 : COMPANY PROFILES 79

17.1. Wuxi AppTec 79

17.1.1. Company Overview 79

17.1.2. Product Portfolio 79

17.1.3. Swot Analysis 79

17.1.4. Business Strategy 80

17.1.5. Financial Overview 80

17.2. Shanghai Bailun Biotechnology Co., Ltd. 81

17.3. Tsinghua University Suzhou Institute for Biomedicine 81

17.4. FUJIFILM Irvine Scientific 81

17.5. Cytiva 81

17.6. Hitachi Chemical Co., Ltd. 81

17.7. Mitsubishi Gas Chemical Company, Inc. 81

17.8. Merck Life Science 81

17.9. Thermo Fisher Scientific Asia 81

17.10. Danaher Asia-Pacific 81

 

List of Figures

FIG NO. 1. South Korea Single-Use Bio-Processing Systems Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for South Korea Single-Use Bio-Processing Systems Market 29

FIG NO. 3. South Korea Single-Use Bio-Processing Systems Market Import Volume/Revenue, By South Korea, 2018 – 2023 31

FIG NO. 4. South Korea Single-Use Bio-Processing Systems Market Export Volume/Revenue, By South Korea, 2018 – 2023 32

FIG NO. 5. South Korea Single-Use Bio-Processing Systems Market Demand Volume/Revenue, By South Korea, 2018 – 2023 33

FIG NO. 6. South Korea Single-Use Bio-Processing Systems Market Supply Volume/Revenue, By South Korea, 2018 – 2023 34

FIG NO. 7. South Korea Single-Use Bio-Processing Systems Market Production Volume/Revenue, By South Korea, 2018 – 2023 35

FIG NO. 8. South Korea Single-Use Bio-Processing Systems Market Price, By Type, 2018 – 2023 36

FIG NO. 9. Raw Materials Price Trend Analysis, 2018 – 2023 37

FIG NO. 10. Manufacturing Cost Analysis 38

FIG NO. 11. Manufacturing Process 38

FIG NO. 12. Value Chain Analysis for South Korea Single-Use Bio-Processing Systems Market 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. Single-Use Bio-Processing Systems Market – Company Volume  Market Share, 2023 43

FIG NO. 18. Single-Use Bio-Processing Systems Market – Company Revenue Market Share, 2023 44

FIG NO. 19. Single-Use Bio-Processing Systems Market Revenue Share, By Type, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Type 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51

FIG NO. 22. Single-Use Bio-Processing Systems Market Revenue, By Type, 2018, 2023, 2027 & 2032 52

FIG NO. 23. South Korea Single-Use Bio-Processing Systems Market for Single-Use Bioreactors, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. South Korea Single-Use Bio-Processing Systems Market for Single-Use Mixers, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. South Korea Single-Use Bio-Processing Systems Market for Single-Use Bags, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. South Korea Single-Use Bio-Processing Systems Market for Single-Use Connectors, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. South Korea Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. Single-Use Bio-Processing Systems Market Revenue Share, By Application, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Application 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60

FIG NO. 31. Single-Use Bio-Processing Systems Market Revenue, By Application, 2018, 2023, 2027 & 2032 61

FIG NO. 32. South Korea Single-Use Bio-Processing Systems Market for Research & Development, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. South Korea Single-Use Bio-Processing Systems Market for Manufacturing, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. South Korea Single-Use Bio-Processing Systems Market for Process Development, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. South Korea Single-Use Bio-Processing Systems Market for Commercial Production, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. South Korea Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. Single-Use Bio-Processing Systems Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. South Korea Single-Use Bio-Processing Systems Market for Pharmaceutical & Biotechnology Companies, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. South Korea Single-Use Bio-Processing Systems Market for Contract Research Organizations (CROs), Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. South Korea Single-Use Bio-Processing Systems Market for Academic & Research Institutes, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. South Korea Single-Use Bio-Processing Systems Market for Contract Manufacturing Organizations (CMOs), Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. South Korea Single-Use Bio-Processing Systems Market for Others, Revenue (USD Million) 2018 – 2032 75

List of Tables

TABLE NO. 1. : South Korea Single-Use Bio-Processing Systems Market: Snapshot 21

TABLE NO. 2. : Drivers for the Single-Use Bio-Processing Systems Market: Impact Analysis 25

TABLE NO. 3. : Restraints for the Single-Use Bio-Processing Systems Market: Impact Analysis 27

TABLE NO. 4. : South Korea Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 36

TABLE NO. 5. : Key Raw Materials & Suppliers 37

TABLE NO. 6. : South Korea Single-Use Bio-Processing Systems Market Revenue, By Type, 2018 – 2023 (USD Million) 76

TABLE NO. 7. : South Korea Single-Use Bio-Processing Systems Market Revenue, By Type, 2024 – 2032 (USD Million) 76

TABLE NO. 8. : South Korea Single-Use Bio-Processing Systems Market Revenue, By Application, 2018 – 2023 (USD Million) 77

TABLE NO. 9. : South Korea Single-Use Bio-Processing Systems Market Revenue, By Application, 2024 – 2032 (USD Million) 77

TABLE NO. 10. : South Korea Single-Use Bio-Processing Systems Market Revenue, By End-user, 2018 – 2023 (USD Million) 78

TABLE NO. 11. : South Korea Single-Use Bio-Processing Systems Market Revenue, By End-user, 2024 – 2032 (USD Million) 78

 

Request Sample

Request Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

cr-clients-logos

Frequently Asked Questions

What is the current size of the South Korea Single-Use Bio-Processing Systems market?

The market was valued at USD 737.89 million in 2024 and is projected to reach USD 2,562.50 million by 2032, growing at a CAGR of 16.84%.

What factors are driving the growth of the South Korea Single-Use Bio-Processing Systems market?

Key drivers include rising demand for biologics, government support, technological innovation, and the shift toward cost-efficient, flexible manufacturing.

What are some challenges faced by the South Korea Single-Use Bio-Processing Systems market?

Challenges include high initial investment costs and sustainability issues related to the disposal of single-use components.

Who are the major players in the South Korea Single-Use Bio-Processing Systems market?

Major players include Wuxi AppTec, FUJIFILM Irvine Scientific, Cytiva, Thermo Fisher Scientific Asia, and Merck Life Science.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

South East Asia Umbilical Cord Blood Market

The South East Asia Umbilical Cord Blood Market size was valued at USD 180.00 million in 2018 to USD 315.69 million in 2024 and is anticipated to reach USD 1,087.29 million by 2032, at a CAGR of 16.79% during the forecast period.

South Korea Electrophysiology Devices Market

South Korea Electrophysiology Devices Market size was valued at USD 477.26 million in 2018 to USD 549.04 million in 2024 and is anticipated to reach USD 1,733.24 million by 2032, at a CAGR of 15.45% during the forecast period.

South Korea Automotive Lead Acid Battery Market

South Korea Automotive Lead Acid Battery market size was valued at USD 896.60 million in 2023 and is anticipated to reach USD 1,913.21 million by 2032, at a CAGR of 8.8% during the forecast period (2023-2032).

South Korea Geospatial Analytics Market

South Korea Geospatial Analytics Market size was valued at USD 3,579.49 million in 2023 and is anticipated to reach USD 8,504.79 million by 2032, at a CAGR of 10.1% during the forecast period (2023-2032).

South Africa Single-Use Bio-Processing Systems Market

South Africa Single-Use Bio-Processing Systems market size was valued at USD 70.83 million in 2024 and is anticipated to reach USD 187.86 million by 2032, at a CAGR of 12.97% during the forecast period (2024-2032).

South Africa Cardiovascular Devices Market

he South Africa Cardiovascular Devices Market is projected to grow from USD 301.65 million in 2024 to an estimated USD 435.58 million by 2032, with a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.

South Korea Industrial Solvents Market

South Korea Industrial Solvents market size was valued at USD 1,476.14 million in 2024 and is anticipated to reach USD 2,695.12 million by 2032, at a CAGR of 7.82% during the forecast period (2024-2032).

South Korea Vendor Neutral Archives (VNA) and PACS Market

South Korea Vendor Neutral Archives (VNA) and Picture Archiving and Communication Systems (PACS) market size was valued at USD 187.86 million in 2024 and is anticipated to reach USD 357.56 million by 2032, at a CAGR of 8.38% during the forecast period (2024-2032).

South Africa Industrial Fasteners Market

The South Africa Industrial Fasteners Market is projected to grow from USD 403.98 million in 2024 to an estimated USD 517.95 million by 2032, with a compound annual growth rate (CAGR) of 3.16% from 2024 to 2032.

Related Reports

Fertility Testing Market

The global fertility testing market is projected to grow from USD 662.7 million in 2024 to USD 1,254.1 million by 2032, registering a CAGR of 8.3% during the forecast period.

Hypertrophic Cardiomyopathy Treatment Market

Hypertrophic Cardiomyopathy Treatment Market size was valued at USD 2293.4 million in 2024 and is anticipated to reach USD 5061 million by 2032, at a CAGR of 10.4% during the forecast period.

Tremor Proof Devices Market

The global tremor proof devices market is projected to grow from USD 523.7 million in 2024 to USD 1,181 million by 2032, registering a CAGR of 10.7% during the forecast period.

Anti-Obesity Drugs Market

The Anti-Obesity Drugs Market size was valued at USD 3,250.0 million in 2018 to USD 6,980.4 million in 2024 and is anticipated to reach USD 36,326.2 million by 2032, at a CAGR of 23.0% during the forecast period.

India Anti-Obesity Drugs Market

The India Anti-Obesity Drugs Market size was valued at USD 30.1 million in 2018 to USD 239.0 million in 2024 and is anticipated to reach USD 3,451.1 million by 2032, at a CAGR of 39.7% during the forecast period.

India Ventilator Market

The India ventilator market size was valued at USD 172 million in 2018 to USD 207 million in 2024 and is anticipated to reach USD 351.12 million by 2032, at a CAGR of 5.68% during the forecast period.

Blockchain Supply Chain Market

The Blockchain Supply Chain Market size was valued at USD 2,496.3 million in 2024 and is anticipated to reach USD 24,002.9 million by 2032, at a CAGR of 32.7% during the forecast period from 2024 to 2032.

Zonisamide Market

The zonisamide market is projected to grow from USD 779 million in 2024 to USD 1,358.6 million by 2032, registering a CAGR of 7.2% during the forecast period.

Noise Monitoring Market

The noise monitoring market is projected to grow from USD 808.1 million in 2024 to USD 1,261 million by 2032, reflecting a CAGR of 5.72% during the forecast period.

Pentavalent Vaccine Market

Pentavalent Vaccine Market size was valued at USD 2726 million in 2024 and is anticipated to reach USD 4027.5 million by 2032, at a CAGR of 5% during the forecast period.

Epilepsy Treatment Drugs Market

The Epilepsy Treatment Drugs Market size was valued at USD 11739.4 million in 2024 and is anticipated to reach USD 18291.4 million by 2032, at a CAGR of 5.7% during the forecast period (2024-2032).

Collagen Peptide And Gelatin Market

The Collagen Peptide and Gelatin Market size was valued at USD 1,448.4 million in 2018 to USD 2,417.3 million in 2024 and is anticipated to reach USD 4,738.9 million by 2032, at a CAGR of 8.81% during the forecast period.

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$8699

Let us help you

Credence Staff 3

WILLIAM, North America

+1 304 308 1216

Support Staff at Credence Research

KEITH PHILLIPS, Europe

+44 7809 866 263

Lee - CR Sales Staff

LEE VALLANCE, Asia Pacific

+64 22 017 0275

Kieran Jameson

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

cr-clients-logos

Request Sample